Tissue Heart Valves - Medical Devices Pipeline Assessment, 2018

  • ID: 4580444
  • Report
  • 123 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Abbott Vascular Inc
  • CryoLife Inc
  • Edwards Lifesciences Corp
  • Medtronic plc
  • Stellenbosch University
  • University of Cambridge
  • MORE
Tissue Heart Valves - Medical Devices Pipeline Assessment, 2018

Summary

The Medical Devices sector report, “Tissue Heart Valves - Medical Devices Pipeline Assessment, 2018" provides an overview of Tissue Heart Valves currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Tissue Heart Valves pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by The team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Tissue Heart Valves under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Tissue Heart Valves and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Tissue Heart Valves under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Vascular Inc
  • CryoLife Inc
  • Edwards Lifesciences Corp
  • Medtronic plc
  • Stellenbosch University
  • University of Cambridge
  • MORE
1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Tissue Heart Valves Overview

3 Products under Development
3.1 Tissue Heart Valves - Pipeline Products by Stage of Development
3.2 Tissue Heart Valves - Pipeline Products by Segment
3.3 Tissue Heart Valves - Pipeline Products by Territory
3.4 Tissue Heart Valves - Pipeline Products by Regulatory Path
3.5 Tissue Heart Valves - Pipeline Products by Estimated Approval Date
3.6 Tissue Heart Valves - Ongoing Clinical Trials

4 Tissue Heart Valves - Pipeline Products under Development by Companies
4.1 Tissue Heart Valves Companies - Pipeline Products by Stage of Development
4.2 Tissue Heart Valves - Pipeline Products by Stage of Development

5 Tissue Heart Valves Companies and Product Overview
5.1 Abbott Vascular Inc Company Overview
5.2 Children's Hospital Boston Company Overview
5.3 Colibri Heart Valve, LLC Company Overview
5.4 CorMatrix Cardiovascular Inc Company Overview
5.5 CryoLife Inc Company Overview
5.6 Cytograft Tissue Engineering Inc (Inactive) Company Overview
5.7 Daidalos Solutions BV Company Overview
5.8 Edwards Lifesciences Corp Company Overview
5.9 Hancock Jaffe Laboratories Inc Company Overview
5.10 LivaNova PLC Company Overview
5.11 Medtronic plc Company Overview
5.12 Revivicor Inc Company Overview
5.13 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
5.14 Stellenbosch University Company Overview
5.15 Tissue Regenix Ltd Company Overview
5.16 University of California Irvine Company Overview
5.17 University of Cambridge Company Overview
5.18 University of Minnesota Company Overview
5.19 University of Zurich Company Overview
5.20 ValveXchange, Inc. (Inactive) Company Overview
5.21 VueKlar Cardiovascular Ltd (Inactive) Company Overview

6 Tissue Heart Valves- Recent Developments
6.1 Jun 05, 2018: Medtronic Presents Strategic Growth Roadmap at 2018 Investor Day; Outlines Plan to Create Shareholder Value
6.2 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results
6.3 May 23, 2018: Abbott's Investigational Tendyne Device for Mitral Valve Replacement Demonstrates Positive Outcomes at 30 Days in Global Study
6.4 May 09, 2018: Computer-Designed Customized Regenerative Heart Valves
6.5 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy
6.6 May 02, 2018: CryoLife Announces First Quarter 2018 Financial Results
6.7 Apr 24, 2018: Edwards Lifesciences Announces First Quarter 2018 Financial Results
6.8 Apr 10, 2018: SUMMIT Trial (U.S. IDE) of the Tendyne Mitral Valve Received Approval From the FDA
6.9 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics
6.10 Mar 26, 2018: Tissue Regenix: Annual results for period ended 31 December 2017
6.11 Mar 22, 2018: LivaNova Announces Enrollment for PERFECT Perceval Valve Clinical Trial in China
6.12 Mar 08, 2018: Tissue Regenix: Full-year 2017
6.13 Mar 07, 2018: CryoLife Reports Fourth Quarter and Full Year 2017 Results
6.14 Feb 28, 2018: LivaNova Announces Fourth Quarter and Full-Year 2017 Results
6.15 Feb 07, 2018: Caisson Interventional Expanding in Maple Grove
6.16 Feb 02, 2018: JenaValve Technology Appoints Laura A. Brenton as Vice President of Clinical and International Market Development
6.17 Feb 01, 2018: Edwards Lifesciences Reports Fourth Quarter Results
6.18 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region
6.19 Jan 25, 2018: Edwards' INSPIRIS RESILIA Valve Approved In Canada
6.20 Jan 11, 2018: LivaNova Initiates BELIEVE Aortic Heart Valve Study in the U.S. and Canada
6.21 Jan 08, 2018: LivaNova Announces Matthew J. Dodds as Senior Vice President, Corporate Development
6.22 Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region
6.23 Dec 07, 2017: Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference
6.24 Dec 01, 2017: Tissue Regenix: Directorate Change
6.25 Nov 21, 2017: Medtronic Reports Second Quarter Financial Results
6.26 Nov 21, 2017: Vickie Capps Joins OmniGuide’s Board of Directors
6.27 Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue
6.28 Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report
6.29 Nov 02, 2017: Tissue Regenix: Steve Couldwell appointed Group CEO
6.30 Nov 02, 2017: LivaNova Reports Third Quarter 2017 Results
6.31 Nov 01, 2017: New tissue-engineered blood vessel replacements closer to human trials
6.32 Oct 30, 2017: CryoLife Reports Third Quarter 2017 Results
6.33 Oct 24, 2017: Edwards Lifesciences Announces Third Quarter Results
6.34 Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria
6.35 Oct 02, 2017: Jeffrey H. Burbank Joins CryoLife Board of Directors
6.36 Sep 24, 2017: Edwards Announces Key Events For PCR London Valves 2017
6.37 Sep 11, 2017: LivaNova Announces Publication of Literature Review Highlighting the Clinical Value and Safety of the Perceval Sutureless Valve for Aortic Valve Replacement
6.38 Aug 23, 2017: OmniGuide Appoints Ajay Bhave as its Chief Technology Officer
6.39 Aug 22, 2017: Medtronic Reports First Quarter Financial Results
6.40 Aug 09, 2017: LivaNova Reports Second Quarter 2017 Results
6.41 Aug 04, 2017: LivaNovas Perceval Sutureless Aortic Heart Valve Awarded New Technology Add-on Payment from the Center for Medicare and Medicaid Services
6.42 Aug 02, 2017: Medtronic Expands Heart Valve Portfolio with FDA Approval and CE Mark of the Avalus Surgical Aortic Valve
6.43 Jul 26, 2017: Edwards Lifesciences Reports Second Quarter Results
6.44 Jul 24, 2017: CryoLife Reports Second Quarter 2017 Financial Results
6.45 Jul 05, 2017: Edward's INSPIRIS RESILIA Valve Receives FDA Approval
6.46 Jun 12, 2017: LivaNova Appoints Keyna Skeffington as Senior Vice President and General Counsel

7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact Us
7.4 Disclaimer

List of Tables
Table 1: Tissue Heart Valves - Pipeline Products by Stage of Development
Table 2: Tissue Heart Valves - Pipeline Products by Segment
Table 3: Tissue Heart Valves - Pipeline Products by Territory
Table 4: Tissue Heart Valves - Pipeline Products by Regulatory Path
Table 5: Tissue Heart Valves - Pipeline Products by Estimated Approval Date
Table 6: Tissue Heart Valves - Ongoing Clinical Trials
Table 7: Tissue Heart Valves Companies - Pipeline Products by Stage of Development
Table 8: Tissue Heart Valves - Pipeline Products by Stage of Development
Table 9: Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Tendyne Bioprosthetic Mitral Valve Implantation System - Product Status
Table 11: Tendyne Bioprosthetic Mitral Valve Implantation System - Product Description
Table 12: Abbott Vascular Inc - Ongoing Clinical Trials Overview
Table 13: Tendyne Bioprosthetic Mitral Valve Implantation System - Expanded Clinical Study of the Tendyne Mitral Valve System
Table 14: Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Heart Valve Leaflet - Product Status
Table 16: Heart Valve Leaflet - Product Description
Table 17: Colibri Heart Valve, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Pulmonary Valve - Product Status
Table 19: Pulmonary Valve - Product Description
Table 20: Sutureless Surgical Aortic Valve - Product Status
Table 21: Sutureless Surgical Aortic Valve - Product Description
Table 22: CorMatrix Cardiovascular Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 23: CorMatrix ECM - Heart Valve Repair - Product Status
Table 24: CorMatrix ECM - Heart Valve Repair - Product Description
Table 25: CorMatrix ECM - Heart Valve Replacement - Product Status
Table 26: CorMatrix ECM - Heart Valve Replacement - Product Description
Table 27: CorMatrix ECM Tricuspid Heart Valve - Product Status
Table 28: CorMatrix ECM Tricuspid Heart Valve - Product Description
Table 29: Regenerating Tubular Mitral Valve - Product Status
Table 30: Regenerating Tubular Mitral Valve - Product Description
Table 31: CorMatrix Cardiovascular Inc - Ongoing Clinical Trials Overview
Table 32: CorMatrix ECM Tricuspid Heart Valve - CorMatrix ECM Tricuspid Valve Replacement Safety and Early Feasibility
Table 33: CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 34: CryoValve SGAV - Product Status
Table 35: CryoValve SGAV - Product Description
Table 36: Synergraft Xenograft Heart Valve - Product Status
Table 37: Synergraft Xenograft Heart Valve - Product Description
Table 38: Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 39: Cytograft Valve - Product Status
Table 40: Cytograft Valve - Product Description
Table 41: Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview
Table 42: Sutureless Aortic valve Prosthesis - Product Status
Table 43: Sutureless Aortic valve Prosthesis - Product Description
Table 44: Sutureless Mitral Valve Prostheses - Product Status
Table 45: Sutureless Mitral Valve Prostheses - Product Description
Table 46: Sutureless Tricuspid Valve Prostheses - Product Status
Table 47: Sutureless Tricuspid Valve Prostheses - Product Description
Table 48: Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 49: GLX Aortic Conduit - Product Status
Table 50: GLX Aortic Conduit - Product Description
Table 51: INSPIRIS RESILIA Aortic Valve - Product Status
Table 52: INSPIRIS RESILIA Aortic Valve - Product Description
Table 53: INTUITY Valve System - Product Status
Table 54: INTUITY Valve System - Product Description
Table 55: KONECT Conduit - Product Status
Table 56: KONECT Conduit - Product Description
Table 57: Magna EASE Surgical Valve With GLX - Product Status
Table 58: Magna EASE Surgical Valve With GLX - Product Description
Table 59: Edwards Lifesciences Corp - Ongoing Clinical Trials Overview
Table 60: INTUITY Valve System - Multi-center Experience with the Rapid Deployment Edwards INTUITY Valve System for Aortic Valve Replacement
Table 61: INTUITY Valve System - Surgical Treatment of Aortic Stenosis with a Next Generation Surgical Aortic Valve
Table 62: Magna EASE Surgical Valve With GLX - Clinical Study to Evaluate the Performance of Magna Ease Heart Valve in Chinese Patients
Table 63: Magna EASE Surgical Valve With GLX - Prospective, Non-randomized, Multicenter Clinical Evaluation of the Edwards Pericardial Aortic and Mitral Bioprostheses (Models 11000a and 11000m) with a New Tissue Treatment Platform: COMMENCE
Table 64: INSPIRIS RESILIA Aortic Valve - Prospective, Non-randomized, Multicenter Clinical Evaluation of the Edwards Pericardial Aortic and Mitral Bioprostheses (Models 11000a and 11000m) with a New Tissue Treatment Platform: COMMENCE
Table 65: Hancock Jaffe Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 66: Bioprosthetic Aortic Heart Valve - Product Status
Table 67: Bioprosthetic Aortic Heart Valve - Product Description
Table 68: Bioprosthetic Mitral Heart Valve - Product Status
Table 69: Bioprosthetic Mitral Heart Valve - Product Description
Table 70: LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
Table 71: Perceval S - Extended Indications - Product Status
Table 72: Perceval S - Extended Indications - Product Description
Table 73: Perceval Sutureless Aortic Valve - XL Version - Product Status
Table 74: Perceval Sutureless Aortic Valve - XL Version - Product Description
Table 75: Perceval Sutureless Heart Valve - Product Status
Table 76: Perceval Sutureless Heart Valve - Product Description
Table 77: LivaNova PLC - Ongoing Clinical Trials Overview
Table 78: Perceval Sutureless Heart Valve - Behavior of Valve Leaflets and the Incidence of Reduced Mobility Post-surgical Aortic Valve Implant
Table 79: Perceval Sutureless Heart Valve - Perceval S Valve Clinical Trial for Extended CE Mark
Table 80: Perceval Sutureless Heart Valve - Perceval Sutureless Implant Versus Standard-aortic Valve Replacement A Controlled Randomized Trial in the Surgical Treatment of Aortic Valve Disease
Table 81: Perceval Sutureless Heart Valve - Perceval Valve Clinical study for Chinese Registration: PERFECT Trial
Table 82: Perceval S - Extended Indications - Behavior of Valve Leaflets and the Incidence of Reduced Mobility Post-surgical Aortic Valve Implant
Table 83: Perceval Sutureless Aortic Valve - XL Version - Behavior of Valve Leaflets and the Incidence of Reduced Mobility Post-surgical Aortic Valve Implant
Table 84: Perceval Sutureless Aortic Valve - XL Version - Perceval Sutureless Implant Versus Standard-aortic Valve Replacement A Controlled Randomized Trial in the Surgical Treatment of Aortic Valve Disease
Table 85: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
Table 86: Closed-Chest Aortic Tissue Valve - Product Status
Table 87: Closed-Chest Aortic Tissue Valve - Product Description
Table 88: Enable Valve-Beating Heart Procedure - Product Status
Table 89: Enable Valve-Beating Heart Procedure - Product Description
Table 90: Revivicor Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 91: Heart Valve - Product Status
Table 92: Heart Valve - Product Description
Table 93: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
Table 94: Tissue Based Cardiac Valve - Product Status

List of Figures
Figure 1: Tissue Heart Valves - Pipeline Products by Stage of Development
Figure 2: Tissue Heart Valves - Pipeline Products by Segment
Figure 3: Tissue Heart Valves - Pipeline Products by Territory
Figure 4: Tissue Heart Valves - Pipeline Products by Regulatory Path
Figure 5: Tissue Heart Valves - Pipeline Products by Estimated Approval Date
Figure 6: Tissue Heart Valves - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Vascular Inc
  • Children's Hospital Boston
  • Colibri Heart Valve, LLC
  • CorMatrix Cardiovascular Inc
  • CryoLife Inc
  • Cytograft Tissue Engineering Inc
  • Daidalos Solutions BV
  • Edwards Lifesciences Corp
  • Hancock Jaffe Laboratories Inc
  • LivaNova PLC
  • Medtronic plc
  • Revivicor Inc
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • Stellenbosch University
  • Tissue Regenix Ltd
  • University of California Irvine
  • University of Cambridge
  • University of Minnesota
  • University of Zurich
  • ValveXchange, Inc.
  • VueKlar Cardiovascular Ltd
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll